Threading the Needle: From Prototype to Product in the Post-COVID Diagnostics Hangover

​Diagnostics founders know the post-COVID reality: the spotlight is gone, the bar is higher, and the money’s tighter. So how do you get a regulated product to market when timelines are long, capital is scarce, and everything still feels like R&D?

​In this open roundtable, we’ll talk about what it really takes to move a diagnostics product from benchtop prototype to something a clinician can use - and how to make progress without burning cash, team morale, or investor trust.

​We’ll cover questions like:

• ​What did you cut from your roadmap - and why?

• ​How do you run preclinical or clinical studies without VC money?

• ​How do you keep your product ‘regulatory-ready’ while iterating fast?

• ​What does “just enough evidence” really mean for fundraising or KOL buy-in?

​This session is especially for founders building hardware/clinical products, but all startup survivors welcome. Expect war stories, shared tactics, and zero pitching.